These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18678563)

  • 1. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
    Hu NW; Smith IM; Walsh DM; Rowan MJ
    Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic plasticity in animal models of early Alzheimer's disease.
    Rowan MJ; Klyubin I; Cullen WK; Anwyl R
    Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Exp Gerontol; 2004; 39(11-12):1661-7. PubMed ID: 15582282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.
    Rowan MJ; Klyubin I; Wang Q; Hu NW; Anwyl R
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1219-23. PubMed ID: 17956317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
    Nomura I; Kato N; Kita T; Takechi H
    Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.
    Klyubin I; Walsh DM; Lemere CA; Cullen WK; Shankar GM; Betts V; Spooner ET; Jiang L; Anwyl R; Selkoe DJ; Rowan MJ
    Nat Med; 2005 May; 11(5):556-61. PubMed ID: 15834427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
    Holscher C; Gengler S; Gault VA; Harriott P; Mallot HA
    Eur J Pharmacol; 2007 Apr; 561(1-3):85-90. PubMed ID: 17320856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.
    Chen L; Yamada K; Nabeshima T; Sokabe M
    Neuropharmacology; 2006 Feb; 50(2):254-68. PubMed ID: 16324726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine.
    Klyubin I; Wang Q; Reed MN; Irving EA; Upton N; Hofmeister J; Cleary JP; Anwyl R; Rowan MJ
    Neurobiol Aging; 2011 Apr; 32(4):614-23. PubMed ID: 19446369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25-35).
    Sun MK; Alkon DL
    J Neurophysiol; 2002 May; 87(5):2441-9. PubMed ID: 11976381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
    Zhang JF; Qi JS; Qiao JT
    Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
    Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
    Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo.
    Cheng L; Yin WJ; Zhang JF; Qi JS
    Synapse; 2009 Mar; 63(3):206-14. PubMed ID: 19072840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo.
    Klyubin I; Walsh DM; Cullen WK; Fadeeva JV; Anwyl R; Selkoe DJ; Rowan MJ
    Eur J Neurosci; 2004 May; 19(10):2839-46. PubMed ID: 15147317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons.
    Wang DC; Chen SS; Lee YC; Chen TJ
    Neurosci Lett; 2006 May; 398(1-2):78-82. PubMed ID: 16412575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.
    Schmid AW; Lynch MA; Herron CE
    Hippocampus; 2009 Jul; 19(7):670-6. PubMed ID: 19115392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
    Bisel BE; Henkins KM; Parfitt KD
    Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.